Results 81 to 90 of about 5,863 (212)

Desmoplastic melanoma in Sweden in 2009–2022: A population‐based registry study demonstrating distinctive tumour characteristics, incidence and survival trends

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page 90-98, January 2026.
The incidence of desmoplastic melanoma (DM) in Sweden remains stable, unlike rising cutaneous melanoma rates. Despite advanced tumour features, DM patients have better survival outcomes. However, recent survival improvements are lacking, potentially due to limited treatment options compared to other melanoma subtypes.
Yodit Girmay   +5 more
wiley   +1 more source

Lentigo Maligna: Clinical Presentation and Appropriate Management

open access: yesClinical, Cosmetic and Investigational Dermatology, 2020
Helena Iznardo,1,* Cristina Garcia-Melendo,1,* Oriol Yélamos1,2 1Dermatology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Dermatology Service, Centro Médico Teknon – Quir ...
Iznardo H, Garcia-Melendo C, Yélamos O
doaj  

Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma

open access: yesCancer Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Uveal melanoma (UM) is the prevailing malignant tumor that develops within the eye in adults, and it has a bleak outlook because of the few treatment choices available and the high likelihood of returning after treatment. Currently, surgical intervention, radiation therapy, and a combination of both modalities are available ...
Alireza Azani   +13 more
wiley   +1 more source

Desmoplastic melanoma associated with an intraepidermal lentiginous lesion: case report and literature review Melanoma desmoplásico associado a lesão lentiginosa intraepidérmica, com evolução de 10 anos: relato de caso e revisão bibliográfica

open access: yesAnais Brasileiros de Dermatologia, 2013
Desmoplastic melanoma tends to present as firm, amelanotic papules. Microscopically, it reveals a proliferation of fusiform cells in the dermis and variable collagen deposition, as well as intraepidermal melanocytic proliferation of lentiginous type in ...
Cesar de Souza Bastos Junior   +2 more
doaj  

Multi‐task AI models in dermatology: Overcoming critical clinical translation challenges for enhanced skin lesion diagnosis

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 12, Page 2121-2133, December 2025.
Our All‐In‐One framework for skin lesion diagnosis—Hierarchical‐Out of Distribution—Clinical Triage (HOT) model provides three outputs—(1) Hierarchical classification; (2) An Out‐of‐Distribution (OOD) alert; and (3) A clinical triage recommendation for the input clinical image of lesion.
Deval Mehta   +11 more
wiley   +1 more source

Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism

open access: yesAdvanced Science, Volume 12, Issue 43, November 20, 2025.
Melanoma, an aggressive skin cancer, arises from dynamic interactions between genetic, environmental, and lifestyle factors. This review explores how age, gender, obesity, diet, exercise, smoking, alcohol, UV exposure, circadian rhythms, and medications influence melanoma risk and progression.
Hanbin Wang   +4 more
wiley   +1 more source

Malignant melanoma and other malignancies of the nasal cavity and the paranasal sinuses in Sweden [PDF]

open access: yes, 2014
Background: Malignancies emerging in the nasal cavity and the paranasal sinuses are rare and accounts for 5% of all head and neck malignancies and 0.1% of all malignancies in Sweden. The incidence of sinonasal malignancy (SNM), except sinonasal malignant
Jangard, Mattias
core   +1 more source

Stromal cell effects on melanoma cell drug response [PDF]

open access: yes, 2013
Thesis (M.A.)--Boston UniversityObjective: Melanoma is currently one of the deadliest forms of skin disease in the United States. However in the past decade there have been significant advances in treatment.
Della Penna, Greg
core   +1 more source

Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports [PDF]

open access: yes, 2014
Ipilimumab is a monoclonal antibody that blocks cytotoxic T-lymphocyte antigen4 (CTLA-4), an inhibitory molecule typically expressed on T cells. Blockade of CTLA-4 induces an overall activation of T cells, including an immune-mediated anti-tumour ...
Brochez, Lieve   +4 more
core   +2 more sources

Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma [PDF]

open access: yes, 2018
Purpose: To evaluate the diagnostic accuracy of contrast-enhanced FDG-PET/CT (ce-PET/CT), PET-only, and CT-only in patients with newly diagnosed and resected cutaneous malignant melanoma.
Antoch, Gerald   +8 more
core  

Home - About - Disclaimer - Privacy